CREATE Medicines Inc. (formerly Myeloid Therapeutics), a biotechnology company advancing in vivo immune-cell programming with mRNA-LNP therapeutics, today announced first-in-human results from its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback